NKCC1 imbues glioma cells with a great transformation power that enables them to cross the extremely narrow extracellular space; the volume of a migrating glioma cell can be reduced to 30%–50% of the initial volume (Watkins & Sontheimer, 2011). Here, SLC12A2 is linked to central nervous system cancer.